{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04732416",
            "orgStudyIdInfo": {
                "id": "HM-GCG-201"
            },
            "organization": {
                "fullName": "Hanmi Pharmaceutical Company Limited",
                "class": "INDUSTRY"
            },
            "briefTitle": "HM15136 Treatment for 8 Weeks in Subjects Aged \u22652 Years With Congenital Hyperinsulinism (CHI)",
            "officialTitle": "A Phase 2, Multiple Ascending Dose, Open-label, Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HM15136 Treatment for 8 Weeks in Subjects Aged \u22652 Years With Congenital Hyperinsulinism (CHI)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "treatment-for-weeks-in-subjects-aged-years-with-congenital-hyperinsulinism-chi"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2021-10-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-01-20",
            "studyFirstSubmitQcDate": "2021-01-26",
            "studyFirstPostDateStruct": {
                "date": "2021-02-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Hanmi Pharmaceutical Company Limited",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15136 when used as add-on therapy in subjects with CHI with persistent hypoglycemia while on standard of care treatment (SoC). HM15136 will be administered once weekly in multiple doses to subjects in multiple age including pediatric to find appropriate exposure-response data."
        },
        "conditionsModule": {
            "conditions": [
                "Congenital Hyperinsulinism"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 16,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "HM15136 active",
                    "type": "EXPERIMENTAL",
                    "description": "Cohort 1 / Cohort 2",
                    "interventionNames": [
                        "Drug: HM15136"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "HM15136",
                    "description": "Low dose of HM15136/ High dose of HM15136, SC injection, weekly",
                    "armGroupLabels": [
                        "HM15136 active"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of incidence of AEs, TEAE, SAE as assessed by CTCAE v5.0",
                    "timeFrame": "after multiple subcutaneous (SC) doses of 8 weeks"
                },
                {
                    "measure": "Number of incidence of clinical laboratory abnormalities",
                    "timeFrame": "after multiple subcutaneous (SC) doses of 8 weeks"
                },
                {
                    "measure": "Maximum Serum Concentration [Cmax]",
                    "timeFrame": "after multiple subcutaneous (SC) doses of 8 weeks"
                },
                {
                    "measure": "Time to reach Cmax",
                    "timeFrame": "after multiple subcutaneous (SC) doses of 8 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male and female subjects aged \u22652 years with CHI with persistent hypoglycemia despite current SoC treatment according to the investigator's evaluation or documentation\n* Stable therapy with SoC medications with or without nutritional supplementation\n* Previously undergone near-total pancreatectomy or being treated with a nonsurgical approach, having been evaluated as not eligible for pancreatic surgery\n* HbA1c \\<7%\n\nExclusion Criteria:\n\n* Subjects with type 1 or type 2 diabetes mellitus\n* Other reasons for hypoglycemia, including but not limited to drug-induced hyperinsulinemic hypoglycemia, etc\n* Treatment of CHI with continuous intravenous glucose or glucagon infusion within 3 months prior to screening\n* Subjects with current use of any drugs that are known to interfere with the study drug, glucose metabolism, or study procedures (eg, use of systemic glucocorticoids \\[excluding topical, intra-articular or ophthalmic application, nasal spray, or inhaled forms\\] or insulin)\n* Have conditions that could affect glucose levels such as pheochromocytoma, insulinoma, and glucagonoma",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "2 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "JinHee Byeon",
                    "role": "CONTACT",
                    "phone": "+82 2 410 0485",
                    "email": "jinhee.byeon@hanmi.co.kr"
                }
            ],
            "locations": [
                {
                    "facility": "University of California Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Erin Okawa",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "TERMINATED",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "The Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lauren Mitteer",
                            "role": "CONTACT",
                            "phone": "267-426-9915",
                            "email": "MitteerL@chop.edu"
                        },
                        {
                            "name": "Diva De Leon-Crutchlow",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Otto-von-Guericke-Universitaet Magdeburg",
                    "status": "RECRUITING",
                    "city": "Magdeburg",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Klaus Mohnike",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.12773,
                        "lon": 11.62916
                    }
                },
                {
                    "facility": "Hadassah Medical Center (HMC)",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "David Zangen",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Asan Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "JinHo Choi",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Great Ormond Street Hospital (GOSH) for Children NHS Foundation Trust",
                    "status": "RECRUITING",
                    "city": "London",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Antonia Dastamani",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Central Manchester University Hospitals NHS Foundation Trust - Royal Manchester Children's Hospital - Centre for Paediatrics and Child Health",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Indi Banerjee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000044903",
                    "term": "Congenital Hyperinsulinism"
                },
                {
                    "id": "D000046768",
                    "term": "Nesidioblastosis"
                },
                {
                    "id": "D000006946",
                    "term": "Hyperinsulinism"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                },
                {
                    "id": "D000007003",
                    "term": "Hypoglycemia"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9997",
                    "name": "Hyperinsulinism",
                    "asFound": "Hyperinsulinism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25408",
                    "name": "Congenital Hyperinsulinism",
                    "asFound": "Congenital Hyperinsulinism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25705",
                    "name": "Nesidioblastosis",
                    "asFound": "Congenital Hyperinsulinism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10053",
                    "name": "Hypoglycemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T1510",
                    "name": "Congenital Hyperinsulinism",
                    "asFound": "Congenital Hyperinsulinism",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}